Loading...
Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
Mesalazine is widely used in the treatment of inflammatory bowel disease. Little is known about the dose-response relationship and about possible dose related side effects. In ulcerative colitis higher dosages of mesalazine (3 g) are more effective in maintaining a remission than lower dosages (1.5...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
1998
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1781839/ https://ncbi.nlm.nih.gov/pubmed/9705596 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|